the present invention relates to live attenuated bacteria for use as a medicament . the invention also relates to vaccines based thereon that are useful for the prevention of microbial pathogenesis . further , the invention relates to live attenuated recombinant bacteria carrying a heterologous gene and vaccines based thereon . finally , the invention relates to methods for the preparation of such vaccines and bacteria .